Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
Clinical trial NCT03629171 · RECRUITING
Trial details
- NCT number
- NCT03629171
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2026-12-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.